Cell Hypertrophy and MEK/ERK Phosphorylation are Regulated by Glyceraldehyde-Derived AGEs in Cardiomyocyte H9c2 Cells
- 4 January 2013
- journal article
- research article
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 66 (3) , 537-544
Abstract
Diabetic cardiomyopathy has been shown to promote hypertrophy, leading to heart failure. Recent studies have reported a correlation between diabetic cardiomyopathy and oxidative stress, suggesting that the accumulation of advanced glycation end products (AGEs) induces the production of reactive oxygen species (ROS). In a clinical setting, AGEs have been shown to increase the risk of cardiovascular disease; however, the relationship between AGEs and cardiac hypertrophy remains unclear. This study sought to identify the role of AGEs in cardiac hypertrophy by treating H9c2 cells with glyceraldehyde-derived AGEs (200 μg/ml) or H2O2 (50 μM) for 96 h. Our results demonstrate that AGEs significantly increased protein levels and cell size. These effects were effectively blocked with PD98059 (10 μM; MEK/ERK inhibitor) pretreatment, suggesting that AGEs caused cell hypertrophy via the MEK/ERK pathway. We then treated cells with AGEs and H2O2 for 0–120 min and employed the Odyssey infrared imaging system to detect MEK/ERK phosphorylation. Our results show that AGEs up-regulated MEK/ERK phosphorylation. However, this effect was blocked by NAC (5 mM; ROS inhibitor), indicating that AGEs regulate MEK/ERK phosphorylation via ROS. Our findings suggest that glyceraldehyde-derived AGEs are closely related to cardiac hypertrophy and further identify a molecular mechanism underlying the promotion of diabetic cardiomyopathy by AGEs.Keywords
This publication has 42 references indexed in Scilit:
- S100B Engages RAGE or bFGF/FGFR1 in Myoblasts Depending on Its Own Concentration and Myoblast Density. Implications for Muscle RegenerationPLOS ONE, 2012
- Advanced glycation end-products in myocardium-supported vessels: Effects of heart failure and diabetes mellitusThe Journal of Heart and Lung Transplantation, 2011
- Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndromeHeart Failure Reviews, 2011
- S100B's double life: Intracellular regulator and extracellular signalBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- N-acetylcysteine prevents glucose/glucose oxidase-induced oxidative stress, mitochondrial damage and apoptosis in H9c2 cellsLife Sciences, 2009
- Retracted:Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up‐regulation contribute to the onset of diabetic cardiomyopathyJournal of Cellular and Molecular Medicine, 2008
- Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEsAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Advanced glycation endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytesLife Sciences, 2007
- Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetesDiabetologia, 2006
- Role of the Maillard Reaction in Diabetes Mellitus and Diseases of AgingDrugs & Aging, 1996